5 Stocks That Can Offer High Return: Buy, Add Call Assigned: ICICI Securities

ICICI Securities has recommended investors to buy 5 stocks that are showing potential to offer attractive return. These stocks are Marico, Angel One, Aster DM Healthcare, Metropolis Healthcare, and Westlife Foodworld. If you buy these stocks now, you can get maximum potential return of 42%. Check details below:

1. Add Marico

ICICI Securities has suggested investors to add Marico with a target price of Rs 560 apiece. Current market price of the large cap FMCG stock is Rs 488.70 apiece. The company has a market capitalisation of Rs 63,189.86 crore.

If you add the stock now, it can offer a return of 15%. The stock declined 3% in last 1-year and gave a return of 59% in last 3-years.

Meeting of Board of Directors of the Company is scheduled to be held on February 27, 2023, to consider inter-alia, a proposal for declaration of Interim Equity Dividend, if any, for the Financial Year 2022-23.

According to the analyst, "We continue to believe that Marico's leadership which has a strong track record of outperformance will find solutions in long term."

2. Buy Angel One

The analyst has assigned buy call to Angel One with a target price of Rs 1420 apiece. Current market price of the small cap Financial Sector stock is Rs 1090.35 apiece.

If you buy Angel One now, you can get potential return of 30%. The company has a market capitalisation of Rs 9,094.80 crore. The stock gave negative return of 28% in last 3-months, and 16% in last 1-year. It gave return of 235% in last 2-years.

According to ICICI Securities, "We retain our BUY rating on Angel One on the basis of its continuous business momentum and the currently low valuations (stock trading at 10x FY24E P/E)."

3. Buy Aster DM Healthcare

ICICI Securities has given buy call to Aster DM Healthcare with a target price of Rs 262 apiece. Current market price of the mid cap Hospital sector stock 231.85 apiece.

If you buy the stock now, you can get a potential return of 13%. The company has a market capitalisation of Rs 11,581.21 crore. The stock gave a return of 22% in last 1-year and 35% in last 3-years.
According to the brokerage, "Recent correction in the stock price (~9% in last 3 months) makes valuations reasonable and hence, we upgrade the stock to BUY with a revised SOTP-based target price of Rs262/share (earlier: Rs270/share)."

4. Buy Metropolis Healthcare

The brokerage has maintained buy call with a target price of Rs 1933 apiece. Current market price of Metropolis Healthcare is Rs 1359.40 apiece. If you buy Metropolis Healthcare shares now, you can get likely return of 42%. The company has a market capitalisation of Rs 6,960.98 crore.

The mid cap Diagnostics industry stock gave 4% return in last 1-month and declined 25% in last 1-year.
It announced a dividend of Rs 8.0 per share on 7 February, 2023 with record date of 23 Feb, 2023.

According to ICICI Securities, "We remain positive on the company owing to its aggressive network expansion with focus on B2C, strengthening position in the fast-growing south region with focus on increasing digital revenue and faster shift of the market to organised players."

5. Add Westlife Foodworld

The analyst has recommended investors to add Westlife Foodworld with a target price of Rs 790 apiece. Current market price of the mid cap Tourism & Hospitality sector stock is Rs 666.35 apiece. If you add the stock now, you can get potential return of 19%.

The company has a market capitalisation of Rs 10,390.81 crore. The stock gave a return of 43% in last 1-year and 40% in last 3-years.

According to ICICI Securities, "We maintain our constructive thesis on WESTLIFE and remain longstanding believers in it. Incremental focus towards McCafe, gourmet burgers, fried chicken (in south market), scale-up of convenience channel (one of the best executions), experience of the future (EOTF) stores are driving big gains. Maintain ADD."

 

Disclaimer

The stocks have been picked from the brokerage report of ICICI Securities. Greynium Information Technologies, the Author, and the respective Brokerage House are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before taking any investment decision.